Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke
- 23 November 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 63 (10) , 1971-1973
Abstract
The authors evaluated the long-term efficacy and safety of botulinum toxin type A (BTX-A) in poststroke spasticity patients who completed a 12-week placebo-controlled study and received multiple open-label treatments with 200 to 240 U BTX-A for 42 weeks. Significant and sustained improvements were observed for Disability Assessment and Ashworth scores. Adverse events were generally mild. This extension of a double-blind study demonstrates that repeated treatments of BTX-A significantly improve function and tone in spasticity.Keywords
This publication has 7 references indexed in Scilit:
- Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticityArchives of Physical Medicine and Rehabilitation, 2002
- Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a StrokeNew England Journal of Medicine, 2002
- Post-Stroke Spasticity Management with Repeated Botulinum Toxin Injections in the Upper LimbAmerican Journal of Physical Medicine & Rehabilitation, 2000
- A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injuryClinical Rehabilitation, 2000
- Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patientsClinical Rehabilitation, 1997
- Botulinum toxin type A in the treatment of upper extremity spasticityNeurology, 1996
- The control of muscle tone, reflexes, and movementNeurology, 1980